India Pesticides reports strong Q2 & H1 FY26 results with 26% revenue growth, capacity expansion
India Pesticides reported strong Q2 FY26 results with 26% revenue growth and 22% net profit growth. The company commissioned expanded capacity and approved a new backward integration project, demonstrating strategic growth.
The announcement includes strong financial performance, significant capacity expansion, and a new backward integration project, which are key drivers for future growth and operational efficiency. These developments are likely to have a substantial positive impact on the company's valuation and market position.
The company reported robust year-on-year growth in both revenue and net profit for Q2 and H1 FY26, along with improved EBITDA and ROCE. Strategic capacity expansion and approval of a new backward integration project further indicate positive future prospects, despite a marginal dip in domestic revenue.
India Pesticides Limited (IPL) announced its unaudited consolidated financial results for the quarter and half year ended 30th September 2025, demonstrating significant growth driven by volume and price recovery. The key highlights are: * Q2 FY26 Total Revenue stood at ₹295 crore, marking a 26.0% year-on-year (YoY) increase. * Net Profit for Q2 FY26 was ₹32 crore, up 22.0% YoY, with a PAT margin of 10.7%. * EBITDA increased by 37.6% YoY to ₹54 crore, with margins improving by 167 basis points YoY to 18.3%. * Technical & API segments contributed 66% to the total revenue. * ROCE improved to 18.8% in Q2 FY26 from 17.6% in Q2 FY25. * For H1 FY26, Total Income was ₹579 crore, a 26.4% increase YoY. EBITDA grew by 52.1% YoY to ₹108 crore, with a margin of 18.6%. Net Profit rose 46.6% YoY to ₹67 crore, with a PAT margin of 11.5%.
Operational Highlights: * The expanded formulation facility was commissioned, increasing capacity from 6,500 MT to 10,000 MT per annum with an investment of ₹2.8 crore, funded through internal accruals. * The Board approved a new backward integration project at Sandila for 26 DEA, a key input for herbicides, with a proposed capacity of 4,000 MT and an investment of ₹65 crore. * Export sales nearly doubled to ₹140 crore in Q2 FY26 from ₹74 crore in Q2 FY25, driven by demand recovery in Europe and Australia. * Domestic revenue saw a marginal decline to ₹150 crore due to delayed monsoon and disruptions in the pesticide application cycle.
Mr. Anand S. Agarwal, Director, Founder & Promoter, commented on the consistent performance, strategic focus, and confidence in sustaining growth through continued export demand, gradual domestic market recovery, and benefits from capacity expansion. He also highlighted the company's CSR and sustainability initiatives.
An earnings conference call is scheduled for Thursday, 13th November 2025, at 12:30 PM IST.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.